XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

This new study not only clarifies the causes of gout but also helps scientists explore more treatment options. Existing drugs ...

Insight into the immunopathogenesis of crystal-induced inflammation has opened the door to a new approach to therapy. Could interleukin-1 antagonists be the answer to managing acute gout?

In addition to adherence challenges, discontinuation of prescription treatment due to adverse effects is also a challenge in the medical management of gout.

It has been awarded a fast-track review by the FDA, which Sobi said “underscores the urgent need for new treatment options for patients with chronic refractory gout.” If approved, it will ...

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

Doctor Edward Dwyer knows gout when he sees it. The throbbing agony drives many patients to seek medical help. Doctors generally prescribe one of three different treatments fo this type of searing ...